We are live on ! Find out more
SHPH icon

Shuttle Pharmaceuticals
SHPH

2 hedge funds and large institutions have $39.2K invested in Shuttle Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more capital inflows, than outflows

Capital inflows: $72.4K | Capital outflows: $34.2K

0.49% more ownership

Funds ownership: 0.52% → 1.01% (+0.49%)

33% less funds holding

Funds holding: 3 → 2 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HRT Financial
HRT Financial
New York
+$63.2K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$9.2K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Securities
Two Sigma Securities
New York
-$16.9K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$12.3K
3
Virtu Financial
Virtu Financial
New York
-$5K

SHPH Hedge Fund Activity: Q3 2024 in Review

2 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q3 2024, worth a combined $39.2K — up 13% from $34.6K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SHPH and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $63.2K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $16.9K sold.

  • 2 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q3 2024, down from 3 in Q2 2024.
  • Funds reported $39.2K of Shuttle Pharmaceuticals stock for Q3 2024, up 13% quarter-over-quarter.
  • 2 funds opened new Shuttle Pharmaceuticals positions in Q3 2024 and 3 closed out, a net change of -1 holder.
  • The largest Shuttle Pharmaceuticals buyer in Q3 2024 was HRT Financial, an estimated $63.2K added.
  • The largest Shuttle Pharmaceuticals seller in Q3 2024 was Two Sigma Securities, an estimated $16.9K sold.

Based on aggregated 13F filings for Q3 2024.